TNFSF11 and breast carcinoma: Importantly, women within the high progesterone and high serum RANKL/OPG ratio group carried a 5.3 (95% CI 1.5 - 25.4, p = 0.0169) fold risk to develop breast cancer 12-24 months after diagnosis (Table 4).